isatin
known
year
recent
found
like
endogen
polyfunct
heterocycl
compound
exhibit
biolog
activ
mammal
somogyi
schiff
base
mannich
base
isatin
known
possess
wide
rang
pharmacolog
properti
includ
antibacteri
pandeya
et
al
sarangapani
reddi
varma
nobl
anticonvuls
sridhar
et
al
varma
et
al
antihiv
pandeya
et
al
b
sriram
et
al
antifung
pandeya
et
al
b
antivir
singh
et
al
anticanc
activ
fig
karki
et
al
varieti
util
anticanc
drug
drug
candid
mologni
et
al
beauchard
et
al
zhang
go
andreani
et
al
repres
member
class
sunitinib
pfizer
inc
current
use
clinic
multitarget
tyrosin
kinas
inhibitor
antiangiogen
activ
fig
sun
et
al
groupsubstitut
potent
inhibitor
pdgfra
low
crossreact
panel
kinas
fig
roth
et
al
current
evalu
phase
iii
clinic
trial
treatment
nonsmal
cell
lung
cancer
clinic
develop
tumor
type
indirubin
identifi
activ
ingredi
tradit
chines
recip
danggui
longhui
wan
use
treatment
chronic
myelogen
leukemia
cml
fig
xiao
et
al
thiosemicarbazon
variou
aldehyd
keton
occupi
special
place
among
organ
ligand
sinc
contain
variou
donor
atom
abl
chang
densiti
depend
start
reagent
reaction
condit
studi
extens
due
import
biolog
activ
karki
et
al
sinc
marboran
found
activ
treatment
smallpox
previou
studi
group
reveal
promis
cytotox
anticonvuls
properti
variou
thiosemicarbazon
fig
karki
et
al
therefor
perform
synthesi
new
thiosemicarbazon
deriv
substitut
evalu
cytotox
antivir
antimicrobi
activ
compound
seri
prepar
methodolog
outlin
scheme
synthesi
diethylamino
methyl
deriv
carri
mannich
base
reaction
diethylamin
presenc
formaldehyd
synthesi
hydrazinecarbothioamid
b
carri
react
diethylamino
methyl
deriv
thiosemicarbazid
n
thiosemicarbazid
reflux
ethanol
presenc
catalyt
amount
glacial
acet
acid
spectroscopi
indic
compound
exist
singl
isom
solut
compound
assay
cytotox
human
hela
cem
tlymphocyt
well
murin
cell
data
summar
tabl
compound
cytostat
among
compound
evalu
tumor
cell
line
low
micromolar
rang
potent
inhibitor
murin
cell
prolifer
also
inhibitori
human
tlymphocyt
cem
hela
cell
prolifer
introduct
r
substitut
thiosemicarbazon
deriv
seri
often
led
potent
inhibitor
tumor
cell
prolifer
replac
hydrogen
chlorin
atom
improv
potenti
cytostat
activ
compar
tabl
wherea
replac
chlorin
atom
r
methoxi
group
often
result
mark
equal
potenti
cytostat
activ
replac
hydrogen
atom
r
chlorin
atom
yield
improv
potenc
compar
replac
hydrogen
atom
r
r
chlorin
result
complet
loss
activ
keep
chlorin
atom
r
r
result
slight
improv
cytostat
activ
antivir
screen
b
perform
use
mtsbase
cpe
reduct
assay
kumar
et
al
felin
corona
viru
fipv
felin
herp
viru
crfk
cell
cultur
herp
simplex
ko
ko
herp
simplex
g
vaccinia
viru
vv
vesicular
stomat
viru
vsv
herp
simplex
tk
ko
acvr
tk
ko
acvr
hel
cell
cultur
vsv
coxsacki
viru
respiratori
syncyti
viru
rsv
hela
cell
cultur
influenza
viru
subtyp
influenza
viru
subtyp
influenza
b
viru
mdck
cell
cultur
viru
sindbi
viru
sv
punta
toro
viru
ptv
vero
cell
cultur
compound
exhibit
moder
antivir
activ
hel
cell
comparison
standard
compound
specif
antivir
effect
note
compound
crfk
mdck
vero
cell
cultur
tabl
synthes
compound
screen
inhibitori
activ
result
shown
tabl
compound
name
capabl
inactiv
activ
compound
activ
moder
compar
standard
potassium
clavulan
titl
compound
also
screen
antibacteri
activ
aureu
b
subtili
k
pneumonia
e
coli
p
vulgari
typhi
antifung
activ
niger
c
albican
exhibit
moder
antimicrobi
activ
tabl
synthesi
intermedi
accomplish
use
literatur
methodolog
marvel
heir
previous
report
procedur
use
convert
compound
correspond
diethylamino
methyl
n
requir
prepar
b
prepar
literatur
methodolog
sen
sengupta
lieber
et
al
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
yield
mp
ir
kbr
cs
co
nh
ppm
q
nh
calc
found
antivir
screen
b
perform
fipv
felin
herp
viru
crfk
cell
cultur
ko
vv
vsv
tk
ko
acvr
hel
cell
cultur
vsv
rsv
hela
cell
cultur
sv
ptv
vero
cell
cultur
influenza
viru
subtyp
influenza
viru
subtyp
influenza
b
viru
mdck
cell
cultur
result
express
effect
concentr
cell
grown
confluenc
plate
infect
viru
one
cell
cultur
infect
dose
time
viru
infect
serial
dilut
compound
ad
cultur
incub
day
complet
cpe
observ
infect
untreat
viru
control
cytotox
compound
evalu
parallel
antivir
activ
uninfect
cell
express
minimum
cytotox
concentr
caus
microscop
detect
alter
normal
cell
morpholog
hel
hela
crfk
mdck
vero
cell
cytostat
effect
test
compound
murin
leukemia
cell
human
tlymphocyt
cell
cem
human
cervix
carcinoma
cell
hela
evalu
follow
appropri
number
cell
suspend
growth
medium
allow
prolifer
well
plate
presenc
variabl
amount
test
compound
humidifi
atmospher
h
h
cem
h
hela
number
cell
count
coulter
counter
valu
defin
compound
concentr
requir
inhibit
cell
prolifer
penicillinas
activ
express
pollock
torriani
unit
one
unit
amount
enzym
hydrolyz
sodium
penicillin
g
h
ph
antimicrobi
assay
perform
synthes
compound
cupplat
method
synthes
compound
antibacteri
activ
aureu
b
subtili
k
pneumonia
e
coli
p
vulgari
typhi
antifung
activ
niger
c
albican
activ
express
term
diamet
zone
inhibit
mm
summari
seri
ndiethyl
amino
variou
thiosemicarbazid
moieti
design
synthes
cytotox
synthes
compound
evalu
two
human
cancer
cell
line
cem
hela
murin
leukemia
cell
line
compound
display
excel
cytotox
three
cell
line
test
particular
show
potent
cytotox
cem
cancer
cell
line
preliminari
relationship
sar
studi
reveal
combin
core
structur
phenyl
thiosemicarbazid
moieti
favor
synthes
compound
screen
cytotox
inhibitori
activ
antivir
antibacteri
antifung
activ
variou
strain
microorgan
deriv
show
antivir
activ
hel
cell
cultur
rang
comparison
valu
standard
brivudin
cidofovir
acyclovir
ganciclovir
respect
mild
moder
antimicrobi
activ
observ
encourag
biolog
data
provid
adequ
rational
modif
molecular
scaffold
